Aeterna Zentaris — Company Overview, News & Financial Data

Aeterna Zentaris (NASDAQ:AEZS) is a biopharmaceutical company focused on developing and commercializing novel treatments in oncology, endocrinology and women's health. With a pipeline of innovative therapies aimed at addressing unmet medical needs, the company's research and development strategy prioritizes the advancement of its lead candidates. Aeterna Zentaris is dedicated to improving patient outcomes and enhancing quality of life through groundbreaking scientific research. Its objective is to become a key player in the biopharmaceutical field by delivering effective solutions for conditions with significant treatment gaps.